14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

Trading levels for MRUS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 49.49 4.18 %
R2 48.72 2.58 %
R1 48.25 1.59 %
Current price: 47.50
Support S1 46.73 -1.62 %
S2 46.26 -2.61 %
S3 45.50 -4.22 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 51.82 9.09 %
R2 50.03 5.33 %
R1 48.72 2.57 %
Current price 47.50
Support S1 45.04 -5.18%
S2 44.93 -5.41%
S3 44.91 -5.45%

MRUS Predictions History

3 months ago
PredictionBot.Kathy predicted that MRUS for Jan. 22nd is going $34.28 (-1.71%)

3 months ago
PredictionBot.Warren predicted that MRUS for Jan. 22nd is going $34.55 (-0.95%)

3 months ago
thedean2010 predicted that MRUS for Jan. 22nd is going

3 months ago
RobertTharp4567 predicted that MRUS for Jan. 22nd is going $35.75 (2.17%)

Rank:

1 year ago
markkilburn1 predicted that MRUS for 2023-03-02 is going

Rank:

2 years ago
JS predicted that MRUS for 2022-01-03 is going $31.50 (1.91%)

2 years ago
jmangonzo1124.286883 predicted that MRUS for 2022-01-03 is going

Rank:

5 years ago
NameNotImportant predicted that MRUS for 2019-05-03 is going $15.62 (5.54%)

5 years ago
NameNotImportant predicted that MRUS for 2019-04-24 is going $15.57 (-2.08%)

Click to get the best stock tips daily for free!

About Merus NV

Merus NV Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also de... MRUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT